FDA Commissioner Marty Makary said the agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost ...

Uber has been a great investment for Edward Sheldon, rising more than 100% in just two years. He believes the growth stock is just getting started, however. The post I’ve doubled my money on this ...

For our closing note, the FTSE 100 has finished the day 0.38 per cent down, but still clocks a week more than 1.3 per cent up ...

TEVA stock jumps 21.6% in three months on branded drug growth, biosimilar launches, and margin-boosting cost cuts.

AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase ...

Donald Trump launched new tariffs on Wednesday, which included raising duty on Brazilian imports to 50pc from 10pc, effective ...

WPP shares rallied following yesterday’s slump, putting on 7.8p to 436.4p after announcing Microsoft executive Cindy Rose as ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Citi downgraded Man Group on Wednesday to 'neutral' from 'buy' and slashed its price target on the stock to 185.0p from ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.